hotspot -WSS

hotspot

author：fashion 2025-09-30 19:25:31 - browse：57333

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Gene editing the human germline: What are the risks?

WSS

Precocious puberty in girls comes with mental health risks

Former medical device CEO who sold dummy, plastic parts convicted of fraud

First medicine developed to treat MASH expected to be approved soon

RSV shot was 90% effective at preventing hospitalizations in kids

Positive childhood experiences can help future health

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

IVF, abortion rights issues kick off Biden’s State of the Union

BioMarin wins approval for gene therapy to treat hemophilia A

Neuroscience’s long legacy of racism

Activists slam private health insurers over coverage restrictions

The Readout: Amylyx, Alumis, and Lundbeck drug updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

SCOTUS questions limit to govt efforts to fight misinformation

United colonoscopy coverage change 'may cost lives,' doctors say

Creating egg and sperm cells from stem cells raises ethical issues

Wikipedia

U.K. researchers warn about biases in medical devices, algorithms

Methadone treatment changes are coming. Do they go far enough?

Colonoscopy prep: Liquid

Creating egg and sperm cells from stem cells raises ethical issues

Future doctors should be trained to promote social change

How to bring more disabled researchers into academia

entertainment

Wikipedia

explore

knowledge